ERIN KROLL: Open Payments
NPI 1750110441 · COLFAX, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $115
Food & beverage: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: QULIPTA, Ozempic, TRELEGY ELLIPTA, Auvelity.
Industry payments across WA — which companies pay providers there.
